• Cancer Research

• 1963.

Ferrin Randall Zeitlin Foundation for Sarcoma Research

Mission Statement Our mission is to be a leading provider of financial assistance to sarcoma research programs and to help accelerate the development of new and improved treatments that will eventually lead to a cure for this disease.

• Epilepsy

• 1964.

I CARE I CURE CHILDHOOD CANCER FOUNDATION INC

Nonprofit fighting childhood cancer, one cup at a time.

• Public Health Programs

• 1965.

ASSOCIATION OF PUBLIC HEALTH LABORATORIES INC

A healthier world through quality laboratory systems.

PROJECT KORU

http://www. projectkoru. org Mission: Project Koru enriches lives through community and the outdoors as a way to move forward beyond cancer.

Home Centered Care Institute

HCCI is transforming healthcare by advancing the practice of home-based primary care through innovative house call training programs, advocacy, and research HCCI is transforming healthcare by advancing the practice of home-based primary care through innovative house call training programs, advocacy, and research HCCI is dedicated to creating universal access to best practice house call programs and making home-based primary care the national standard for treating medically complex patients who are better cared for in the home.

• Cancer

• 1968.

Saved for Life Cancer Corporation

HOME S4LCC CANCER STATION CANCER RESOURCES VOLUNTEER OPPORTUNITIES More S.

• Medical Specialty Research

• 1969.

Global Society of Rare Genitourinary Tumors Inc

International Society dedicated to improving the care of rare GU tumors through cutting edge science and the promotion of education.

• Cancer

• 1970.

Akanimo Cancer Foundation

A 501 (c) (3) approved non-profit, created to raise awareness and support for childhood cancer Akanimo Cancer Foundation is dedicated to combating childhood cancer through three key initiatives in the US and Nigeria: 1.

• Birth Defects, Genetic Diseases

• 1971.

SMA-PME Research

Your gift will support ongoing medical research leading to development of an effective treatment to counter the ASAH1 mutations which cause SMA-PME and Farber disease, two extremely rare genetic neurodegenerative diseases that lead to premature death in childhood.